Time to ban ephedra - Now

American Journal of Health-System Pharmacy

Volumn 60, Issue 15, 2003, Pages 1580-1582

  Guharoy, Roy ^a,b,d   Noviasky, John A ^c  

^a STATE UNIVERSITY OF NEW YORK   (United States)

^b State University of New York Upstate Medical University: College of Medicine   (United States)

^c St Elizabeth Medical Center   (United States)

^d University Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; EPHEDRA EXTRACT; MONOAMINE OXIDASE INHIBITOR; PLANT MEDICINAL PRODUCT;

BLEEDING DISORDER; CEREBROVASCULAR ACCIDENT; DIET SUPPLEMENTATION; DRUG ACTIVITY; DRUG INFORMATION; EPHEDRA; FOOD AND DRUG ADMINISTRATION; HEALTH CARE ORGANIZATION; HEALTH CARE POLICY; HEART ARRHYTHMIA; HEART INFARCTION; HEART PALPITATION; HUMAN; HYPERTENSION; NOTE; PATIENT SAFETY; PRIORITY JOURNAL; SEIZURE; STROKE; TACHYCARDIA; UNITED STATES; ARTICLE; CHEMISTRY; DRUG CONTAMINATION; DRUG INTERACTION; LEGAL ASPECT; PHYTOTHERAPY;

DIETARY SUPPLEMENTS; DRUG CONTAMINATION; DRUG INTERACTIONS; EPHEDRA; HUMANS; PHYTOTHERAPY; PLANT PREPARATIONS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 0642338948     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/60.15.1580     Document Type: Note

References (33)

1. Reisen S. Dietary supplement use for pediatric infections. Pediatr Infect Dis J. 2002; 21:683-4.
2. Kaufman DW, Kelly JP, Rosenberg L et al. Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. JAMA. 2002; 287:337-44.
3. Pearson L. Stop dietary supplement health fraud. Nurse Pract. 2002; 27(2): 8-9.
4. Perharic L, Shaw D, Murray V. Toxic effects of herbal medicines and food supplements. Lancet. 1993; 342:180-1. Letter.
5. Duhbabin DW, Tallis GA, Popplewell PY et al. Lead poisoning from Indian herbal medicine (Ayurveda). Med J Aust. 1992; 157:835-6.
6. Kew J, Morris C, Aihie A et al. Arsenic and mercury intoxication due to Indian ethnic remedies. BMJ. 1993; 306:506-7.
7. Slifman NR, Obermeyer WR, Aloi BK et al. Contamination of botanical dietary supplements by Digitalis lanata. N Engl J Med. 1998; 339:806-11.
8. Gurley BJ, Gardner SF, Hubbard MA. Content versus label claims in ephedra-containing dietary supplements. Am J Health-Syst Pharm. 2000; 57:963-9.
9. Gugliotta G. Health concerns grow over herbal aids. Wash Post. 2000; Mar 19.
10. Bonakdar RA. Herbal cancer cures on the Web: noncompliance with the Dietary Supplement Health Education Act. Fam Med. 2002; 34:522-7.
11. Jellin JM, Gregory P, Batz F et al., eds. Pharmacist's letter/prescriber's letter natural comprehensive database. www. naturaldatabase.com (accessed 2003 Apr 11).
12. Mihoces G. Ephedrine: safe or lethal? Debate intensifies as supplement becomes the energy booster of choice for athletes. USA Today. 2001; Nov 8:C1-2.
13. Lindsay B. Are serious adverse cardiovascular events an unintended consequence of the Dietary Supplement Health and Education Act of 1994? Mayo Clin Proc. 2002; 77(1):7-9.
14. General Accounting Office. Testimony. Dietary supplements for weight loss. Limited federal oversight has focused more on marketing than safety, www. gao.gov/new.items/d02985.pdf (accessed 2003 May 28).
15. Haller CA, Jacob P III, Benowitz NL. Pharmacology of ephedra alkaloids and caffeine after single-dose dietary supplement. Clin Pharmacol Ther. 2002; 71:421-32.
16. Gandy W. Severe epinephrine-propanolol interaction. Ann Emerg Med. 1989; 18:98-9.
17. Houben H, Thien T, van 't Laar A. Effect of low-dose epinephrine infusion on hemodynamics after selective and nonselective beta-blockade in hypertension. Clin Pharmacol Ther. 1982; 31:685-90.
18. Van Herwaarden CI, Binkhorst RA, Fennis JF et al. Effects of adrenaline during treatment with propanolol and metoprolol. Br Med J. 1977; 1:1029. Letter.
19. Dawson JK, Earnshaw SM, Graham CS. Dangerous monoamine oxidase inhibitor interactions are still occurring in the 1990s. J Accid Emerg Med. 1995; 12:49-51.
20. McEvoy GK, ed. AHFS drug information. Bethesda, MD: American Society of Health-System Pharmacists; 2003.
21. Dietary supplements containing ephedrine alkaloids. Fed Regist. 1997; 62: 30677-724.
22. Haller CA, Benowitz NL. Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids. N Engl J Med. 2000; 343:1833-8.
23. Samenuk D, Link MS, Homoud MK et al. Adverse cardiovascular events temporally associated with ma huang, an herbal source of ephedrine. Mayo Clin Proc. 2002; 77:12-6.
24. Theoharides TC. Sudden death of a healthy college student related to ephedrine toxicity from ma huang-containing drink. J Clin Psychopharmacol. 1997; 17: 437-9. Letter.
25. Vahedi K, Domingo V, Amarenco P et al. Ischaemic stroke in a sportsman who consumed MaHuang extract and creatine monohydrate for body building. J Neurol Neurosurg Psychiatry. 2000; 68:112-3. Letter.
26. Bruno A, Nolte KB, Chapin J. Stroke associated with ephedrine use. Neurology. 1993; 43:1313-6.
27. From the Centers for Disease Control and Prevention. Adverse events associated with ephedrine-containing products-Texas, December 1993-September 1995. JAMA. 1996; 276:1711-2.
28. Bent S, Tiedt TN, Odden MC et al. The relative safety of ephedra compared with other herbal products. Ann Int Med. 2003; 138:468-71.
29. Food and Drug Administration. HHS acts to reduce safety concerns associated with dietary supplements containing ephedra. www.fda/gov/bbs/topics/ NEWS/ephedra/factsheet.html (accessed 2003 Apr 9).
30. Ephedra: who is protecting American consumers? Statement for the record of the American Medical Association to the subcommittee on oversight of government management, restructuring and the District of Columbia Committee on Government Affairs, United States Senate, October 8, 2002. (Statement of Ron Davis, M.D., American Medical Association) www.senate.gov/~gov_affairs/ 100802davis.htm (accessed 2003 Apr 15).
31. American Society of Health-System Pharmacists. ASHP urges ban of ephedra products. www.ashp.org/news/ShowArticle.cfm?&id=3374 (accessed 2003 Apr 9).
32. Gugliotta G. Heart association urges ban on ephedra. Wash Post. 2003; Apr 4:A02.
33. Schultz S. Mr. outsider moves inside. US News World Rep. 2003; Mar 24:63-5.